Position in ACAD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,081,714
-$1,716,854 QoQ
Shares Held
240,384
-31.4% QoQ
Ownership
0.140%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 354 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,908,415,112 across 370 Biotechnology names. ACAD ranks #172 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in ACAD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,081,714 | 240,384 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $7,798,568 | 350,340 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $19,417,180 | 726,963 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $14,208,384 | 665,810 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,653,137 | 169,362 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,894,308 | 174,251 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $2,532,758 | 138,025 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,497,365 | 97,358 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $38,463,360 | 2,366,976 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $73,845,470 | 3,993,806 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $164,858,358 | 5,265,358 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $110,493,262 | 5,301,980 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $127,443,624 | 5,321,237 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $147,674,385 | 7,846,673 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $148,607,052 | 9,334,614 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $189,301,968 | 11,571,025 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $174,701,303 | 12,398,957 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $326,520,694 | 13,481,449 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $323,043,104 | 13,840,750 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $263,709,395 | 15,876,544 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $378,023,975 | 15,499,138 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $443,437,060 | 17,187,483 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,041,021,981 | 19,472,914 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $814,619,354 | 19,748,348 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,007,706,033 | 20,790,304 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $857,290,398 | 20,290,897 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||